Phase 2 trails ARE fully funded. This huge investment is going to fund cognitive decline in diabetes (1 billion/yr market) and most likely going to test accurately how xanamem inhibits 11 beta hsd1. Note that phase one studies proved that it breaks the blood brain barrier in sufficient concentrations to (theoretically) inhibit 11 beta hsd1. It was very difficult to accurately test this up until recently.
So, based on what I have seen today, we have a safe drug, which has proved its efficacy to the point that a recommendatiin has been made to start a phase 2 trial for diabetes which is funded, not to mention is most likely not far away from commencing based on the fact it has already been delayed. Edinburgh university as far as i know are conducting this study, and were most likely waiting on funding and proof of safety which they now have.
I dont understand why the share price is so low but its probably the best outcome for the LT holders, time to load up on something that has just been majorly derisked.
- Forums
- ASX - By Stock
- Ann: $15m Placement Completed-Including US Cornerstone Investor
Phase 2 trails ARE fully funded. This huge investment is going...
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
-0.007(8.64%) |
Mkt cap ! $200.3M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.2¢ | $548.8K | 7.212M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 377845 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 377845 | 0.074 |
2 | 286985 | 0.073 |
2 | 116109 | 0.072 |
4 | 152568 | 0.071 |
9 | 780796 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 50000 | 1 |
0.076 | 64068 | 1 |
0.077 | 111062 | 2 |
0.078 | 243218 | 5 |
0.079 | 189896 | 3 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online